In our previous study, we found that cholangiocarcinoma-like HCC (CLHCC), a novel HCC subtype that highly expresses HNF-1β and expresses cholangiocarcinoma-like traits and stem cell-like expression traits, tended to show poorer surgical outcome. Here, HNF1B is linked to hepatocellular carcinoma.